Oxford BioMedica PLC
LSE:OXB

Watchlist Manager
Oxford BioMedica PLC Logo
Oxford BioMedica PLC
LSE:OXB
Watchlist
Price: 412.5 GBX -1.43% Market Closed
Market Cap: 434.6m GBX
Have any thoughts about
Oxford BioMedica PLC?
Write Note

Wall Street
Price Targets

OXB Price Targets Summary
Oxford BioMedica PLC

Wall Street analysts forecast OXB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OXB is 489.73 GBX with a low forecast of 308.05 GBX and a high forecast of 777 GBX.

Lowest
Price Target
308.05 GBX
25% Downside
Average
Price Target
489.73 GBX
19% Upside
Highest
Price Target
777 GBX
88% Upside
Oxford BioMedica PLC Competitors:
Price Targets
MRKR
Marker Therapeutics Inc
341% Upside
YMAB
Y-mAbs Therapeutics Inc
78% Upside
MRNA
Moderna Inc
137% Upside
BCYC
Bicycle Therapeutics PLC
73% Upside
301080
Acrobiosystems Co Ltd
14% Upside
301207
Hualan Biological Bacterin Inc
48% Upside
BONEX
Bonesupport Holding AB
7% Downside
ARGX
argenx SE
7% Downside

Revenue
Forecast

Revenue Estimate
Oxford BioMedica PLC

For the last 8 years the compound annual growth rate for Oxford BioMedica PLC's revenue is 24%. The projected CAGR for the next 3 years is 34%.

24%
Past Growth
34%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Oxford BioMedica PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Oxford BioMedica PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OXB's stock price target?
Price Target
489.73 GBX

According to Wall Street analysts, the average 1-year price target for OXB is 489.73 GBX with a low forecast of 308.05 GBX and a high forecast of 777 GBX.

What is Oxford BioMedica PLC's Revenue forecast?
Projected CAGR
34%

For the last 8 years the compound annual growth rate for Oxford BioMedica PLC's revenue is 24%. The projected CAGR for the next 3 years is 34%.

Back to Top